166 related articles for article (PubMed ID: 29624912)
1. Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2-Benzyl-5-nitroindazole-Derived Amines.
Fonseca-Berzal C; Ibáñez-Escribano A; Vela N; Cumella J; Nogal-Ruiz JJ; Escario JA; da Silva PB; Batista MM; Soeiro MNC; Sifontes-Rodríguez S; Meneses-Marcel A; Gómez-Barrio A; Arán VJ
ChemMedChem; 2018 Jun; 13(12):1246-1259. PubMed ID: 29624912
[TBL] [Abstract][Full Text] [Related]
2. Antichagasic and trichomonacidal activity of 1-substituted 2-benzyl-5-nitroindazolin-3-ones and 3-alkoxy-2-benzyl-5-nitro-2H-indazoles.
Fonseca-Berzal C; Ibáñez-Escribano A; Reviriego F; Cumella J; Morales P; Jagerovic N; Nogal-Ruiz JJ; Escario JA; da Silva PB; Soeiro Mde N; Gómez-Barrio A; Arán VJ
Eur J Med Chem; 2016 Jun; 115():295-310. PubMed ID: 27017556
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles.
Boiani L; Gerpe A; Arán VJ; Torres de Ortiz S; Serna E; Vera de Bilbao N; Sanabria L; Yaluff G; Nakayama H; Rojas de Arias A; Maya JD; Morello JA; Cerecetto H; González M
Eur J Med Chem; 2009 Mar; 44(3):1034-40. PubMed ID: 18706738
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological properties of new 5-nitroindazole derivatives.
Arán VJ; Ochoa C; Boiani L; Buccino P; Cerecetto H; Gerpe A; González M; Montero D; Nogal JJ; Gómez-Barrio A; Azqueta A; López de Ceráin A; Piro OE; Castellano EE
Bioorg Med Chem; 2005 May; 13(9):3197-207. PubMed ID: 15809155
[TBL] [Abstract][Full Text] [Related]
5. Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles.
Ibáñez-Escribano A; Reviriego F; Vela N; Fonseca-Berzal C; Nogal-Ruiz JJ; Arán VJ; Escario JA; Gómez-Barrio A
Bioorg Med Chem Lett; 2021 Apr; 37():127843. PubMed ID: 33556576
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug.
Vega MC; Rolón M; Montero-Torres A; Fonseca-Berzal C; Escario JA; Gómez-Barrio A; Gálvez J; Marrero-Ponce Y; Arán VJ
Eur J Med Chem; 2012 Dec; 58():214-27. PubMed ID: 23124218
[TBL] [Abstract][Full Text] [Related]
7. Trypanocidal and leishmanicidal activities of flavonoids isolated from Stevia satureiifolia var. satureiifolia.
Beer MF; Frank FM; Germán Elso O; Ernesto Bivona A; Cerny N; Giberti G; Luis Malchiodi E; Susana Martino V; Alonso MR; Patricia Sülsen V; Cazorla SI
Pharm Biol; 2016 Oct; 54(10):2188-95. PubMed ID: 26983579
[TBL] [Abstract][Full Text] [Related]
8. 3-[4'-bromo-(1,1'-biphenyl)-4-yl]-N, N-dimethyl-3-(2-thienyl)-2-propen-1-amine: synthesis, cytotoxicity, and leishmanicidal, trypanocidal and antimycobacterial activities.
de Souza AO; Hemerly FP; Busollo AC; Melo PS; Machado GM; Miranda CC; Santa-Rita RM; Haun M; Leon LL; Sato DN; de Castro SL; Durán N
J Antimicrob Chemother; 2002 Nov; 50(5):629-37. PubMed ID: 12407118
[TBL] [Abstract][Full Text] [Related]
9. Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant
Fonseca-Berzal C; da Silva CF; Batista DDGJ; de Oliveira GM; Cumella J; Batista MM; Peres RB; Silva da Gama Nefertiti A; Escario JA; Gómez-Barrio A; Arán VJ; Soeiro MNC
Parasitology; 2020 Sep; 147(11):1216-1228. PubMed ID: 32530391
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus.
da Rosa R; Zimmermann LA; de Moraes MH; Schneider NFZ; Schappo AD; Simões CMO; Steindel M; Schenkel EP; Bernardes LSC
Bioorg Med Chem Lett; 2018 Nov; 28(20):3381-3384. PubMed ID: 30194008
[TBL] [Abstract][Full Text] [Related]
11. Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles.
Fonseca-Berzal C; Escario JA; Arán VJ; Gómez-Barrio A
Parasitol Res; 2014 Mar; 113(3):1049-56. PubMed ID: 24435615
[TBL] [Abstract][Full Text] [Related]
12. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.
Rodríguez J; Arán VJ; Boiani L; Olea-Azar C; Lavaggi ML; González M; Cerecetto H; Maya JD; Carrasco-Pozo C; Cosoy HS
Bioorg Med Chem; 2009 Dec; 17(24):8186-96. PubMed ID: 19900812
[TBL] [Abstract][Full Text] [Related]
13. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
[TBL] [Abstract][Full Text] [Related]
17. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
[TBL] [Abstract][Full Text] [Related]
18. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
[TBL] [Abstract][Full Text] [Related]
19. Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.
Reviriego F; Olmo F; Navarro P; Marín C; Ramírez-Macías I; García-España E; Albelda MT; Gutiérrez-Sánchez R; Sánchez-Moreno M; Arán VJ
Parasitology; 2017 Aug; 144(9):1133-1143. PubMed ID: 28367781
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
